The stress hyperglycemic ratio can predict the no-reflow phenomenon following saphenous vein graft intervention in patients with acute coronary syndrome
ÖF Demir, NÖ Şensoy, E Akpınar, G Demir - Acta Diabetologica, 2024 - Springer
Aims The no-reflow phenomenon (NRP) is a common complication of saphenous vein graft
(SVG) interventions. The aim of this study was to investigate the effect of the stress …
(SVG) interventions. The aim of this study was to investigate the effect of the stress …
[PDF][PDF] FGF-21: a novel biomarker predicting no-reflow in ST-segment elevation myocardial infarction.
D Koprulu, K Toprak, G TAPAR… - European Review for …, 2024 - europeanreview.org
OBJECTIVE: Primary percutaneous coronary intervention (pPCI) is the most effective
reperfusion therapy in the treatment of ST-elevation myocardial infarction (STEMI). Although …
reperfusion therapy in the treatment of ST-elevation myocardial infarction (STEMI). Although …
The effect of the systemic immune–inflammatory index on the no-reflow phenomenon in patients undergoing saphenous vein intervention
AC Cakmak, İ Kocayigit, P Varım, BS Çakmak… - … Cardiology/Postępy w …, 2024 - termedia.pl
Aim: In this study, we aimed to investigate the relationship between no-reflow phenomenon
and SII during percutaneous intervention on saphenous vein grafts. Material and methods: A …
and SII during percutaneous intervention on saphenous vein grafts. Material and methods: A …
A new inflammatory marker of the no-reflow phenomenon after Percutaneous Coronary Intervention (PCI) to saphenous venous in patients with coronary artery …
Background: Although numerous mechanisms regarding the no-reflow phenomenon (NRP)
have been mentioned, they have not yet been fully elucidated. The NRP can impact the …
have been mentioned, they have not yet been fully elucidated. The NRP can impact the …